首页 > 期刊杂志 > 正文

Tumor Spread Through Air Spaces Is an Independent Predictor of Recurrence-free Survival in Patients With Resected Lung Squamous Cell Carcinoma.

肿瘤气道内扩散是肺鳞状细胞癌患者术后无复发生存的一个独立预后因子

Kadota K,Kushida Y,Katsuki N,Ishikawa R,Ibuki E,Motoyama M,Nii K,Yokomise H,Bandoh S,Haba R

Abstract

Tumor spread through air spaces (STAS) is a newly recognized pattern of invasion in lung adenocarcinoma. However, clinical significance of STAS has not yet been characterized in lung squamous cell carcinoma. In this study, we investigated whether STAS could determine clinical outcome in Japanese patients with lung squamous cell carcinoma. We reviewed tumor slides from surgically resected lung squamous cell carcinomas (n=216). STAS was defined as tumor cells within air spaces in the lung parenchyma beyond the edge of the main tumor. Tumors were evaluated for histologic subtypes, tumor budding, and nuclear diameter. Recurrence-free survival (RFS) was analyzed using the log-rank test and the Cox proportional hazards model. Tumor STAS was observed in 87 patients (40%), increasing incidence with lymph node metastasis (P=0.037), higher pathologic stage (P=0.026), and lymphatic invasion (P=0.033). All cases with STAS showed a solid nest pattern. The 5-year RFS for patients with STAS was significantly lower than it was for patients without STAS in all patients (P=0.001) and in stage I patients (n=134; P=0.041). On multivariate analysis, STAS was an independent prognostic factor of a worse RFS (hazard ratio=1.61; P=0.023). Patients with STAS had a significantly increased risk of developing locoregional and distant recurrences (P=0.012 and 0.001, respectively). We found that tumor STAS was an independent predictor of RFS in patients with resected lung squamous cell carcinoma, and it was associated with aggressive tumor behavior.

摘要

肿瘤气道内扩散(STAS)是肺腺癌中新近认识的一个侵袭性标志。然而,STAS的临床意义在肺鳞状细胞癌中还未被发掘。此项研究中,我们探讨了STAS在日本的肺鳞状细胞癌患者中是否具有临床预后意义。回顾性分析肺鳞状细胞癌术后切片(n=216)。STAS定义为肿瘤主体边缘之外的肺间质气道内出现肿瘤细胞。肿瘤的组织学亚型、肿瘤的边界和核直径均进行评估。无复发生存期(RFS)则采用对数秩和检验和COX比例风险模型进行评估。87名患者(40%)中观察到STAS,这些患者的淋巴结转移率显著升高(P=0.037)、病理学分级更高(P=0.026)、淋巴侵犯比例更高(P=0.033)。所有STAS病例都呈现一种实性巢团模式。所有患者、以及I期患者中,出现STAS者的5年RFS显著低于无STAS患者(所有患者比较,P=0.001)(I期患者n=134;P=0.041)。在多重变量分析中,STAS是RFS更差的一个独立预后因子(风险比=1.61;P=0.023)。STAS患者发生局部和远处转移的风险显著增加(P分别为0.012、0.001)。我们发现肿瘤STAS是肺鳞状细胞癌患者术后RFS的一个独立预后因子,并且它与肿瘤的侵袭性行为相关。

full text

我要评论

0条评论